尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Caughey Elaine, Directeur Commercial. Director active across 1 company, notably Kymera Therapeutics, Inc.. Cumulatively, 2 reports have been recorded. Activity tracked since 1 March 2022. The latest transaction was filed on 1 March 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Caughey Elaine serves as the Chief Business Officer at Kymera Therapeutics, Inc. She is responsible for the company's commercial strategy, including sales development and marketing. Her expertise in the biopharmaceutical sector is crucial for the success of the company's commercial initiatives.